Role of image guidance in thermal therapy Thermal Dosimetry Issues In Thermal Therapy • Facilitate more optimized treatment Spinal cord – planning – targeting/localizing VX-2 – monitoring/control – verification R. Jason Stafford, PhD Department of Imaging Physics • Imaging information synergistic with integration of model based simulation HIFU Ablation in Rabbit Paraspinal Muscle @1.5T • Endgame – increase safety + efficacy – facilitate minimally invasive approaches previously not considered possible/safe AAPM Ultrasound Symposium 2011 (Vancouver, BC) Thermal therapy energy sources — Treatment prescription Prescribed sonication point Thermal dose (point) — Thermal dose (total) Hazle JD, Stafford RJ, Price RE ,JMRI 15 (2): 185-94., 2002. Challenges for real-time monitoring Multi-element U/S applicators • Cryotherapy HIFU Interstitial/Intracavitary Externally focused high-intensity ultrasound kernal Water cooled interstitial or transurethral ultrasound applicator • Radiofrequency • Microwave • Laser • Ultrasound 3 mm 30 mm High intensity focused ultrasound (FUS or HIFU) 4 mm Focused ultrasound beam Faster delivery Dt ~resolution 10 sec High Small Volume 25 Slower delivery Dt ~ 10mm minutes Lower resolution Larger Volume 1 Modalities for image-guided thermal therapy Modalities for image-guided thermal therapy T 2 P re • US T 2 T reat T 2 P o st T 2 P o st T 1 T reat T 1 + C P o st T 1+ C P ost T issu e P ath o lo g y • US A p p lica to r • CT • CT • MRI • MRI T 1 P re Multi-element U/S applicator therapy Non-invasive Non-ionizing Arbitrary oblique plane orientation Near real-time acquisition speeds Multiple contrast mechanisms for - anatomy - function - metabolism P ath & D o se — Isodose: t 4 3 = 50 m in. - temperature … Example: MRgLITT in canine brain MR Temperature Imaging (MRTI) • Diffusion Predicting outcomes using temperature history • Proton resonance frequency (PRF) of water shifts linearly with temperature • Thermal damage is cumulative effect • Sensitivity: -0.01 ppm/°C (water) • Damage as function of exposure can be modeled as an Arrhenius rate process (W) • T1-relaxation • PRF Shift Tissue Type (Canine) • Advantages Brain Temp. Range (ºC) Temp. Sensitivity (ppm/ºC) 25-59 -0.0102 + 0.0005 – Prostate Reasonable temperature sensitivity 32-59 -0.0099 + 0.0004 – Relatively independent of tissue type+ 0.0006 Kidney 35-54 -0.0103 – Fast, Liver gradient echo 35-51based acquisitions -0.0098 + 0.0002 Bone (femur) Amplitude (A.U.) 17-57 – Less sensitive at low field strengths – Lipid is insensitive to temperature – Sensitive to background field changes • Motion, susceptibility, etc water (-OH) t W A e Ea R T ( ) d -1.2 0 1.2 Frequency (ppm) DT R = Universal Gas Constant A = Frequency Factor (3.1 x 10 98 s-1) Ea = Activation Energy (6.3 x 10 5 J) 5ºC Normal Canine Brain (Henriques FC, Arch Pathol, 1947; 43: p. 489.) 0 • Cumulative Equivalent minutes @ 43°C (CEM43) – Empirically derived from isoeffects observed in low temperature hyperthermia work: n D t C E M 43 ( t n ) R t0 ( 43 T n ) 0.25 T n 43 C D t , w ith R = 0.50 T n 43 C Sapareto SA, Dewey WC Int. J. Rad. Onc. Bio. Phys. 10: 787-800, 1984. -2.4 laser fiber 30ºC – Isotherm characterization of bioeffects limited -0.0109 + 0.0002 • Disadvantages aliased lipid (-CH2) 12s HIFU sonication MRgFUS isodose models W>1 T > 57ºC CEM43 > 240 min 2.4 Modern Review: Rieke, V. & Butts Pauly, K, JMRI, 27:376-90 (2008); 2 Arrhenius rates and a connection between A and E Imaging versus Histology 30ºC 15s FUS exposure in vivo (skeletal muscle) ln(A*Dt)=ln(W)-E/RT 25 W ln(A*Dt) Dt T for W=1 1s 60.1°C 5s 57.2°C 30s 54.1°C 240m 43.8°C 50 W DT 75 W (from regression) 100 W E (Joules) 85 points plotted from literature reports of Arrhenius fits 1cm 125 W A variety of tissues, cells, biological macromolecules and endpoints and heating rates over the range of 43°C-80°C are represented Doubling Dt results in the familiar ~1°C change for equivalent damage of CEM43 0ºC T2-W (PRF-MRTI) T2-W FSE (post) T2W-FSE (t43>240min) Wright NT, J Biomech Eng. 2003 Apr;125(2):300-4 Dice Similarity Coefficient Arrhenius Damage (W) Bias: 54.0+299.4 mm 3 DT (°C) canine prostate Regression and Bland-Altman Analysis Pathology/H&E (Cogaulation,Edema, t43>240min) canine brain Arrhenius Dose (W>1) () Outer rim of T1+C enhancement () Bias: 7.35+20.1 mm 2 Subject DSC 1 0.92 2 0.91 3 0.91 4 0.93 Dice similarity coefficient (DSC): DSC # in te rse ctin g a v e ra g e 2 X Y X Y mean+s 0.92+0.01 (Yung, JP, et al, Med Phys. 2010 Oct;37(10):5313-21) 3 Logit dose analysis of ex vivo changes in tissue R2* FCSI for Multiparametric Imaging Guidance R2* (Hz) fiber ΔR2* (Hz) ΔT1-W Amplitude (%) Temperature (°C) 37°C 50 Hz Arrhenius Dose {W/(1+W)} 2.5% 70°C 0% 0 Hz W(LD50) = 0.77+ 0.40 W(LD50) = 1.10 + 0.32 W(LD50) = 0.85+ 0.49 W(LD50) = 0.97+ 0.30 W(LD50) = 1.10+ 0.25 W(LD50) = 1.00 + 0.14 T (C) Isotherm lines for damage from the Arrhenius dose rate model correlate well with areas where inflection is seen in the slope of R2*(T). Calculated Dice Similarity Coefficient (DSC) = 0.84 DR2* Derived Arrhenius Probit analysis of thermal dose: McDannold NJ, et al, MRM 2004; Above results: Taylor BA, et al, JMRI 2010. Taylor, BA, Stafford, RJ, iMRI Symposium 2010 (submitted to NMR in Biomed) Arrhenius rate processes for alternative isoeffects Multi-element IUS heating (15 min @ 7W) Multi-element IUS heating (15 min @ 7W) Arrhenius rate processes for alternative isoeffects T1+C (sub) (15 min heating) W>1 N-K pump (Grinberg 2001) DT> 54°C (Isotherm for 30sec) W>1 Vascular stasis (Brown 1992) W > 1 (skin) (Pearce SPIE 2009) T1+C (sub) (15 min heating) CEM43 > 240 min FD > 0.5 (Sapareto-Dewey 1984) (Pearce, SPIE 2009) W>1 ATP synth e (Wang 1993) W > 1 (skin) (Henriques 1943) DT> 54°C (Isotherm for 30sec) W>1 Cyt C (Liggins 1999) W > 1 (skin) (Henriques 1943) W > 1 (skin) (Pearce SPIE 2009) CEM43 > 240 min FD > 0.5 (Sapareto-Dewey 1984) (Pearce, SPIE 2009) 4 Multi-element IUS heating (15 min @ 7W) Arrhenius rate processes for alternative isoeffects Fast Chemical Shift Imaging (FCSI) for MRTI N rf F ID ( t ) C Gf H (z) 16-echo MFGRE for fast CSI W>1 (Pearce, SPIE 2009) W > 1 (skin) (Henriques 1943) B(z) A( z ) (Sapareto-Dewey 1984) FD > 0.5 (Pearce, SPIE 2009) n z n n 1 dn n z n Cn n 1 Im ln( n ) Dt R e ln( n ) Dt B(n ) n A ( n ) 20 Amplitude (A.U.) lipid peaks 15 10 water Susceptibility induced error corrected using lipid reference 5 0 water -5 -10 ΔT(δW-L) CSI (Difference) ΔT(δW) CSI (Water Only) -15 5ºC CEM43 > 240 min w (t ) MR Spectrum (1 voxel from image) DT W>1 ATP synth e (Wang 1993) i n d n T E n n0 Q CSI-MRTI in a Canine Femur 30ºC W>1 HSP70 Expression (Beckham 2004) Temperature Change (°C) DT> 54°C (Isotherm for 30sec) e P GΦ T1+C (sub) (15 min heating) n n 1 Gs CPDΔT(Δ -20 -2.4 -1.2 Temperature Probe for verification 0 1.2 Frequency (ppm) 2.4 φ) Fluoroptic Flouroptic ProbeProbe -25 0 100 200 300 400 500 600 700 800 Time (sec) Taylor BA, et al., Medical Physics. 2008;35(2):793-803.; Taylor BA, et al., Medical Physics. 2009;36(3): 753-764. PRF-MRTI of FUS in breast Fast CSI for MRTI 3-Peak Lipid 3-Peak Lipid Multi-planar, multi-shot EPI MRTI facilitated real-time MRTI with high spatiotemporal resolution, high SNR and lipid suppression Water 3-Peak Lipid Water and Lipid 5 T1-W MRTI for Adipose Tissue Fast CSI of FUS in canine prostate Fluoroptic Probe Temperature (C) Adipose Tissue Gel Water PRF Adipose Temperature Sensitivity Calibration W-F T2* 30 T1-W Signal (R2* corrected) Laser 25 20 15 10 TSC = -0.56 +/- 0.05 %/C 5 0 Arrhenius Dose (W) Taylor BA, et al, NMR Biomed (2011) Adipose R2* (Hz) Temperature (C) breakpoint at W=1 Temperature (C) Hynynen K, McDannold N, Mulkern RV, Jolesz FA., MRM 2000 Jun;43(6):901-4. Challenges for PRF MRTI in the Body Coupling MRTI feedback to models • Motion distorts both anatomy & magnetic field – Need to correct both for integrated damage estimate – Breath holds can provide reasonable results c • Background B0 correction Challenges Background field drift Intra/inter scan motion Through plane motion Applicator susceptibility Variable SNR (tissue/time) Real-time (instantaneous) Gating, navigators, multi-baseline techniques Internal reference techniques (i.e., lipid) Referenceless techniques (Rieke V, et al 2004) Real-time modeling and simulation with MR feedback Real-time (cumulative) – – – – magnitude Below: MR-guided laser ablation in liver with background phase-correction temperature (uncorrected) temperature (corrected) 77ºC T ( qi , t ) [( k T ( qi , t ))] b CbV k 1 T Ta P ( qi , t ) t heat diffusion heat convection heat source Pennes Bioheat Equation useful for modeling therapy: HEAT SOURCES (laser, ultrasound, RF, etc) : P = Power absorbed (W m-3) 42ºC Arrhenius Dose Arrhenius Dose mean magnitude (uncorrected) (corrected) HEAT CONDUCTION (diffusion): T = temperature (Kelvin) c = specific heat of material (J kg-1 ºC-1) ρ = density (kg/m3) k = thermal conductivity of tissue (W m -1 ºC-1) HEAT CONVECTION (effects of perfusion): b = blood density (kg m-3) V = volume flow rate per unit volume (s -1) Cb = specific heat of blood (J kg-1 ºC-1) k = dimensionless convection scale factor Pennes HH, J Appl Physiol. 1: 93–122 (1948) 6 Dynamic Data Driven, Model Constrained MRTI MRTI (°C) Uncertainty (°C) Simulated Data Loss MDACC MRTI = Dynamic Input Algorithm compares uncertainty in input verses uncertainty in model and provides an optimal estimate Can help compensate for noisy, missing or corrupt data Can help in optimal interpolation or retrospective filtering Kalman Predicted MRTI Measured MRTI ( 95% CI for 57°C Isotherm) (°C) Acknowledgements & Collaborators Computation intensive, requires highly parallelized, high performance computing to perform in real-time (work in progress) Imaging Physics • John Hazle, PhD • Edward F. Jackson, PhD • R. Jason Stafford, PhD • Luc Bidaut, PhD • Ken-Pin Hwang, PhD • Jim Bankson, PhD • • • Andrew Elliot, PhD David Fuentes, PhD • • Brian Taylor Joshua Yung • • Krista McAlee, RT(R)MR Brandy Reed, RT(R)MR Marites Melancon, PhD Experimental Diagnostic Imaging • Chun Li, PhD • Marites Melancon, PhD Interventional Radiology MRI • Kamran Ahrar, MD • Judy Ahrar, MD • Sanaz Javdi, MD • Yvette Valenzuela, RT(R)MR Neurosurgery BrainSUITE™ • Jeff Weinberg, MD • Rice University • Naomi Halas, PhD • Jennifer West, PhD • Lee Hirsch, PhD • Scott Sershen, PhD Van Luu, RT(R)MR Urology • John Ward, MD Veterinary Medicine & Surgery • Peggy Tinkey, DVM • Rajesh Uthamanthil, DVM, PhD • Agatha Bourne, DVM, PhD • Sherry Klumpp, PhD University of Texas - Austin • Tinsley Oden, PhD • Kenneth Diller, PhD University of Texas – San Antonio • Yusheng Feng, PhD Biotex, Inc • Ashok Gowda, PhD • Roger McNichols, PhD • Anil Shetty, MD, ME • Kevin Pham Nanospectra Biosciences, Inc • Don Payne • Jon Schwartz, PhD Work supported in part by: NIH CA79282, NIH AG19276, NIH CA101573, NIH 5T32CA119930, NSF CNS-0540033, NSF IIS-0325550, NSF IIO-0548741 David Fuentes, PhD The diseases which medicines cannot cure, excision cures: those which excision cannot cure, are cured by the cautery; but those which the cautery cannot cure, may be deemed incurable. - Hippocrates Aphorisms (400 BCE) Thank you for your time! Email: jstafford@mdanderson.org 7